Search Results 391-400 of 17064 for pharmacogenetics
ROCHESTER, Minn. — Sept. 25, 2013 — A Mayo Clinic researcher, along with his collaborators, has shown that an individual's genomic makeup and diet interact ...
A condition of blood plasma that produces altered antibodies that increase the risk of blood cancers and other conditions.
Combinations of biological substances in brentuximab vedotin may be able to carry cancer-killing substances directly to Hodgkin lymphoma cells. Drugs used in ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Pharmacogenetics in dermatology: a patient-centered update. Int J Dermatol. 2013 Aug; 52(8):1005-12. Epub 2013 Jun 20. View PubMed; Comfere NI, Gonzalez ...
There's still time! ... Hurry to 3X your gift's impact on cancer research and care! Triple My Impact.
Jad P. AbiMansour, M.D., is a gastroenterologist at Mayo Clinic who studies complex endoscopic procedures for pancreatic neuroendocrine tumors and diseases ...
Elhaik E, Behnamian S, Howe M, Tang H, Yan H, Tian S, Shivaram S, Zepeda Mendoza C, MacLachlan K, Usmani S, Pirooznia M, Morgan G, Blaney P, Maura F, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!